Efficacy and safety of linagliptin monotherapy in Asian patients with inadequately controlled type 2 diabetes mellitus: A multinational, 24-week, randomized, clinical trial

AIMS/INTRODUCTION: Asian patients represent a large portion of the global population with type 2 diabetes mellitus, but are underrepresented in trials of glucose-lowering therapies. The present randomized, phase III, placebo-controlled, double-blind, 24-week study evaluated the dipeptidyl peptidase-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuhong, Ning, Guang, Wang, Changjiang, Gong, Yan, Patel, Sanjay, Zhang, Candice, Izumoto, Toshiyasu, Woerle, Hans-Juergen, Wang, Weiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627547/
https://www.ncbi.nlm.nih.gov/pubmed/26543544
http://dx.doi.org/10.1111/jdi.12346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627547/
https://www.ncbi.nlm.nih.gov/pubmed/26543544
http://dx.doi.org/10.1111/jdi.12346

Ejemplares similares